FindTrial
Sign In

Comparing buprenorphine and fentanyl as additives to intrathecal ropivacaine under spinal anaesthesia

Comparing the effects of intrathecal buprenorphine versus fentanyl as adjuvant to hyperbaric ropivacaine in lower limb surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/055980
Enrollment
76
Registered
2023-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil

Sponsors

Department of Anesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of ASA 1-2 undergoing lowerlimb surgeries under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Bleeding disorders Local skin infections Raised intracranial pressure Morbid obesity Height less than 150cm

Design outcomes

Primary

MeasureTime frame
To compare Buprenorphine & Fentanyl when given intrathecally as an adjuvant to hyperbaric ropivacaine in terms of 1. Sensory blockade 2. Motor blockade 3. Incidence of bradycardia Incidence of hypotensionTimepoint: The sensory & motor block levels assessment was performed at 5 mins interval for the first 15mins then 15 mins interval for half an hour followed postoperative room (first one hour of shifting)—

Secondary

MeasureTime frame
To compare buprenorphine & fentanyl when given intrathecally as an adjuvant to hyperbaric ropivacaine in terms of 1. Incidence of nausea and vomiting 2. Incidence of pruritis and other side effectsTimepoint: Nausea, vomiting, post operative pain & pruritis will be assessed hourly in post operative unit upto 12 hours—

Countries

India

Contacts

Public ContactKaturi Srilakshmi

KS HEGDE MEDICAL ACADEMY

gaibhat@gmail.com8008283176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026